HBMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 17.1% based on the discounted cash flow analysis.
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $177.08 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.91 |
| Beta | 0.9 |
| Outstanding Shares | 18,807,000 |
| P/E Ratio | -25.73 |
|---|---|
| PEG | -67.47 |
| Price to Sales | 5.83 |
| Price to Book Ratio | 1.46 |
| Enterprise Value to Revenue | 2.03 |
| Enterprise Value to EBIT | 4.55 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 1.36 |
| Debt to Equity | 0.78 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data